F-18 16 alpha-fluoroestradiol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for F-18 16 alpha-fluoroestradiol, covering 2014-12-25 to 2014-12-25. Get the full timeline:
Most recent: Clinical Trial Update: F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer [Phase 2]